$JRSS
JRSIS HEALTH CARE Corp Stock $jrss

$jrss Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000121390024036467 Filed on April 26, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$597.4K	$3.405M	$3.462M
YoY Change	1279.13%	3718.6%	3782.57%
Cost Of Revenue	$411.3K	$2.979M	$2.979M
YoY Change	38.11%		75.96%
Gross Profit	$186.1K	$426.2K	$483.1K
YoY Change	369.85%		1742.93%
Gross Profit Margin	31.15%	12.52%	13.95%
Selling, General & Admin	$295.2K	$482.4K	$482.4K
YoY Change	110.88%	278.43%	29.78%
% of Gross Profit	158.63%	113.19%	99.86%
Research & Development	$9.599K	$189.3K	$189.3K
YoY Change	-74.97%		-33.13%
% of Gross Profit	5.16%	44.41%	39.18%
Depreciation & Amortization	$2.639K	$43.82K	$16.51K
YoY Change		1957.28%	184.85%
% of Gross Profit	1.42%	10.28%	3.42%
Operating Expenses	$304.8K	$271.5K	$671.6K
YoY Change	103.22%	104.13%	61.82%
Operating Profit	-$118.7K	$154.7K	-$188.6K
YoY Change	13.06%		-42.13%
Interest Expense	-$15.89K	-$53.38K	$56.44K
YoY Change
% of Operating Profit		-34.51%
Other Income/Expense, Net	$1.871K	$156.4K	$103.0K
YoY Change		-9086.78%	-89.51%
Pretax Income	-$116.8K	$257.7K	-$85.61K
YoY Change	11.28%	-665.61%	-73.87%
Income Tax	$2.908K	$8.980K	$8.975K
% Of Pretax Income		3.48%
Net Earnings	-$102.4K	$262.4K	-$80.91K
YoY Change	-2.45%	-675.92%	-103.47%
Net Earnings / Revenue	-17.15%	7.71%	-2.34%
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	82.59M shares	5.837M shares	77.25M shares
Diluted Shares Outstanding	84.60M shares		77.25M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$445.9K	$118.1K	$118.1K
YoY Change	1386.33%	101.48%	101.48%
Cash & Equivalents	$445.9K	$118.1K
Short-Term Investments
Other Short-Term Assets	$200.5K	$420.1K	$399.1K
YoY Change	-64.83%	-42.96%	-45.81%
Inventory	$397.8K	$455.2K	$455.2K
Prepaid Expenses
Receivables	$555.8K	$714.7K	$835.7K
Other Receivables	$26.57K	$4.730K	$25.71K
Total Short-Term Assets	$1.828M	$1.834M	$1.834M
YoY Change	195.92%	129.57%	129.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$43.27K	$50.02K	$53.30K
YoY Change	30.9%	28.3%	-6.7%
Goodwill
YoY Change
Intangibles	$242.2K	$257.3K
YoY Change		-15.13%
Long-Term Investments
YoY Change
Other Assets		$0.00	$0.00
YoY Change
Total Long-Term Assets	$286.3K	$310.6K	$310.6K
YoY Change	553.98%	443.76%	443.74%
TOTAL ASSETS
Total Short-Term Assets	$1.828M	$1.834M	$1.834M
Total Long-Term Assets	$286.3K	$310.6K	$310.6K
Total Assets	$2.114M	$2.145M	$2.145M
YoY Change	219.62%	150.54%	150.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$565.5K	$801.3K	$801.3K
YoY Change	6968.5%	3142.64%	3142.78%
Accrued Expenses	$18.06K	$114.8K	$215.4K
YoY Change	80.63%	519.65%	1063.23%
Deferred Revenue		$218.3K
YoY Change
Short-Term Debt	$1.359M	$983.0K	$983.0K
YoY Change
Long-Term Debt Due	$24.38K	$18.71K	$18.71K
YoY Change		-62.35%
Total Short-Term Liabilities	$2.114M	$2.280M	$2.280M
YoY Change	2946.0%	5174.52%	5174.65%
LONG-TERM LIABILITIES
Long-Term Debt	$12.19K	$24.95K	$24.95K
YoY Change
Other Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Liabilities	$12.19K	$24.95K	$24.95K
YoY Change		1644.76%	1644.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.114M	$2.280M	$2.280M
Total Long-Term Liabilities	$12.19K	$24.95K	$24.95K
Total Liabilities	$2.126M	$2.305M	$2.282M
YoY Change	2963.56%	5061.5%	5009.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.691M	-$3.443M
YoY Change	-84.58%	-85.48%
Common Stock	$8.460K	$8.259K
YoY Change	1351.11%	-85.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$7.401K	-$137.4K	-$137.4K
YoY Change
Total Liabilities & Shareholders Equity	$2.114M	$2.145M	$2.145M
YoY Change	219.62%	150.54%	150.54%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$102.4K	$262.4K	-$80.91K
YoY Change	-2.45%	-675.92%	-103.47%
Depreciation, Depletion And Amortization	$2.639K	$43.82K	$16.51K
YoY Change		1957.28%	184.85%
Cash From Operating Activities	-$268.9K	$536.7K	$516.7K
YoY Change	-2788.6%	697.15%	-83.15%
INVESTING ACTIVITIES
Capital Expenditures	$9.160K	$1.480K	$1.484K
YoY Change		-185.55%	-96.68%
Acquisitions
YoY Change
Other Investing Activities		$20.37K	$20.37K
YoY Change			-100.73%
Cash From Investing Activities	-$9.160K	$18.89K	$18.89K
YoY Change		998.26%	-100.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	402.6K	-568.4K	-$568.4K
YoY Change			-23.01%
NET CHANGE
Cash From Operating Activities	-268.9K	536.7K	$516.7K
Cash From Investing Activities	-9.160K	18.89K	$18.89K
Cash From Financing Activities	402.6K	-568.4K	-$568.4K
Net Change In Cash	124.6K	-12.76K	-$40.70K
YoY Change	1145.5%	-118.48%	-94.9%
FREE CASH FLOW
Cash From Operating Activities	-$268.9K	$536.7K	$516.7K
Capital Expenditures	$9.160K	$1.480K	$1.484K
Free Cash Flow	-$278.0K	$535.2K	$515.2K
YoY Change	-2880.2%	675.04%	-82.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	0-56013
CY2023	dei	Entity Registrant Name EntityRegistrantName	JRSIS HEALTH CARE CORPORATION
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4562047
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Xiaoxiang Science and Technology Innovation Center
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Yongzhou Economic and Technology Development Zone
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Hunan Province
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	425000
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	City Area Code CityAreaCode	+86
CY2023	dei	Local Phone Number LocalPhoneNumber	760-88963658
CY2023	dei	Security12b Title Security12bTitle	None
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	5629521	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82594105	shares
CY2023	dei	Auditor Name AuditorName	HHC
CY2023	dei	Auditor Location AuditorLocation	New York
CY2023	dei	Auditor Firm AuditorFirmId	5867
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118114	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	158813	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	714658	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	683452	usd
CY2023Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	345961	usd
CY2022Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	46954	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	455240	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	562015	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	77211	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24600	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1833890	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1663628	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4576	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50024	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62223	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	257334	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	303195	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3277	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7686	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	310635	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	377680	usd
CY2023Q4	us-gaap	Assets Assets	2144525	usd
CY2022Q4	us-gaap	Assets Assets	2041308	usd
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	983007	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1575780	usd
CY2023Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	18713	usd
CY2022Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	49709	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	540086	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	272243	usd
CY2023Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	218313	usd
CY2022Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	10130	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	18845	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	73301	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	221869	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	110109	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	5930	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3277	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6589	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2280227	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2107416	usd
CY2023Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	24950	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2235	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2305177	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2109651	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82594105	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82594105	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	76757439	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76757439	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	8259	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7676	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3154373	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3154881	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3442898	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3361986	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	142860	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	140976	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-137406	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-58453	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-23246	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-9890	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-160652	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-68343	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2144525	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2041308	usd
CY2023	us-gaap	Revenues Revenues	3461933	usd
CY2022	us-gaap	Revenues Revenues	1719130	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	2978882	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1692919	usd
CY2023	us-gaap	Gross Profit GrossProfit	483051	usd
CY2022	us-gaap	Gross Profit GrossProfit	26211	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	146334	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	144651	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	336049	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	283293	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	189266	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	283043	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	671649	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	710987	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-188598	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-684776	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	3058	usd
CY2023	us-gaap	Interest Expense InterestExpense	56443	usd
CY2022	us-gaap	Interest Expense InterestExpense	64709	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	156370	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	76225	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	102985	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11516	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-85613	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-673260	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8975	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-94588	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-673260	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-13676	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-97421	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-80912	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-575839	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-94588	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-673260	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2204	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	53189	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-92384	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-620071	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-13356	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-89725	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-79028	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-530346	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77253156	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61334331	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.001
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.009
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-343269	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	894997	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-673260	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	53189	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-68343	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	75	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-94588	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2204	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-160652	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-94588	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-673260	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	53815	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	34903	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4201	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	10138	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	225	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	325	usd
CY2023	jrss	Inventories Imparementreturn InventoriesImparementreturn	-42439	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-173	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4457	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-909	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	50854	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	679905	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-61511	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-666190	usd
CY2023	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	301154	usd
CY2022	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	32497	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-128663	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-57324	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	50557	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	2185	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	276356	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	11257	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	261901	usd
CY2023	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	209031	usd
CY2022	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-1167459	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-52504	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	347	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5534	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	114021	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	11002	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	516724	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1764729	usd
CY2023	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	20369	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1484	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	18885	usd
CY2022	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	927591	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	467455	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	893539	usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	1021349	usd
CY2022	jrss	Proceeds From Financing Lease ProceedsFromFinancingLease	37157	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-14471	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-568365	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1858287	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-7943	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-7998	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-40699	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	85560	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	158813	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73253	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118114	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	158813	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4945	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	909	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	56443	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	58524	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	5392000	shares
CY2023	us-gaap	Profit Loss ProfitLoss	-94588	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-673260	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3442898	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	516724	usd
CY2023Q4	jrss	Working Capital WorkingCapital	446337	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Use of Estimates</b></span></td></tr></table><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities on the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The Company bases its estimates and judgments on historical experience and on various other assumptions and information that are believed to be reasonable under the circumstances. Estimates and assumptions of future events and their effects cannot be perceived with certainty and, accordingly, these estimates may change as new events occur, as more experience is acquired, as additional information is obtained and as our operating environment changes. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Significant estimates and assumptions made by management include, among others, useful lives and impairment of long-lived assets, collectability of accounts receivable, discount rate of leases and its impairment assessment, allowance for inventory, revenues recognition, deferred tax and uncertain tax positions. While the Company believes that the estimates and assumptions used in the preparation of the consolidated financial statements are appropriate, actual results could differ from those estimates.</span></p>
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Reclassification</b></span></td></tr></table><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Certain prior year balances were reclassified to conform to the current year’s presentation with consideration of reflecting the acquisition transaction by entering into and executing four agreements with Yongzhou Jumi Intelligent Technology Co., Ltd. (“Yongzhou JIT”) and Guangzhou Jumi Intelligent Equipment Co., Ltd. (“Guangzhou JIE”). None of these reclassifications had an impact on reported financial position or cash flows for any of the periods presented.</span></p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	82318	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	583	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	189266	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	283043	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.50	pure
CY2023Q4	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	7.0999	pure
CY2022Q4	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	6.8972	pure
CY2023Q4	us-gaap	Foreign Currency Exchange Rate Remeasurement1 ForeignCurrencyExchangeRateRemeasurement1	7.0809	pure
CY2022Q4	us-gaap	Foreign Currency Exchange Rate Remeasurement1 ForeignCurrencyExchangeRateRemeasurement1	6.729	pure
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	714658	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	683452	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	714658	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	683452	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	302322	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	329335	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	128900	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	229032	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	212364	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	241099	usd
CY2023Q4	jrss	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	643586	usd
CY2022Q4	jrss	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	799466	usd
CY2023Q4	us-gaap	Inventory Adjustments InventoryAdjustments	188346	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	237451	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	455240	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	562015	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	usd
CY2023Q4	us-gaap	Inventory Parts And Components Net Of Reserves InventoryPartsAndComponentsNetOfReserves	42439	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	20981	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	22034	usd
CY2023Q4	us-gaap	Supplies Supplies	1408	usd
CY2022Q4	us-gaap	Supplies Supplies	2566	usd
CY2023Q4	jrss	Vat Deductible VATDeductible	-51714	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	3108	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	77211	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	24600	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	77211	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24600	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	0	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	0	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	147576	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	240825	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	97552	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	178602	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50024	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62223	usd
CY2023	us-gaap	Depreciation Depreciation	16510	usd
CY2022	us-gaap	Depreciation Depreciation	4352	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	372049	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	382983	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-114715	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-79788	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	257334	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	303195	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	37305	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	39256	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	37205	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	37205	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	37205	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	37205	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	37205	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	71309	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	257334	usd
CY2020Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	1768	usd
CY2021Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	929	usd
CY2023	jrss	Rental Fees Percentage RentalFeesPercentage	0.0475	pure
CY2023	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	369	usd
CY2023	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	2615	cny
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3277	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7686	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	3277	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	7686	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	5930	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3277	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6589	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2235	usd
CY2023Q4	us-gaap	Lease Deposit Liability LeaseDepositLiability	3277	usd
CY2022Q4	us-gaap	Lease Deposit Liability LeaseDepositLiability	14754	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	9065	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	232	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	4432	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	4663	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	74765	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	78675	usd
CY2023	us-gaap	Lease Cost LeaseCost	79197	usd
CY2022	us-gaap	Lease Cost LeaseCost	92635	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5534	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8740	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y9M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3315	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3315	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	38	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3277	usd
CY2023	us-gaap	Revenues Revenues	3461933	usd
CY2022	us-gaap	Revenues Revenues	1719130	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2978882	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1692919	usd
CY2023	us-gaap	Gross Profit GrossProfit	483051	usd
CY2022	us-gaap	Gross Profit GrossProfit	26211	usd
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	1732763	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	1335401	usd
CY2023	jrss	Revenues Percentage RevenuesPercentage	0.50	pure
CY2022	jrss	Revenues Percentage RevenuesPercentage	0.78	pure
CY2023	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	819209	usd
CY2022	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	647422	usd
CY2023	jrss	Purchase Percentage PurchasePercentage	0.31	pure
CY2022	jrss	Purchase Percentage PurchasePercentage	0.37	pure
CY2022	us-gaap	Proceeds From Partnership Contribution ProceedsFromPartnershipContribution	894997	usd
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	983007	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1575780	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	43663	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	49709	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	18713	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	49709	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	24950	usd
CY2023	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	52569	usd
CY2022	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	64709	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	58243	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	26964	usd
CY2023Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	39147	usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	19189	usd
CY2022Q4	jrss	Social Security Payable SocialSecurityPayable	2433	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	9720	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	61523	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	221869	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	110109	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-23246	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-9890	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-79028	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-13356	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-530346	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-89725	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	23233689	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4879075	usd
CY2023	jrss	Unified Income Tax Rate UnifiedIncomeTaxRate	0.25	pure
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	85537	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	673260	usd
CY2023	jrss	Effective Income Tax Rate Reconcilation Statutory Income Tax Rate EffectiveIncomeTaxRateReconcilationStatutoryIncomeTaxRate	0.25	pure
CY2022	jrss	Effective Income Tax Rate Reconcilation Statutory Income Tax Rate EffectiveIncomeTaxRateReconcilationStatutoryIncomeTaxRate	0.25	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-21384	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-168315	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	4518	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	25841	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	168315	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8975	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	15830	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	67492	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	969	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1435	usd
CY2023Q4	jrss	Withholding Personal Tax WithholdingPersonalTax	176	usd
CY2022Q4	jrss	Withholding Personal Tax WithholdingPersonalTax	475	usd
CY2023Q4	jrss	Other Levies OtherLevies	1870	usd
CY2022Q4	jrss	Other Levies OtherLevies	3899	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	18845	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	73301	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-80912	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-575839	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77253156	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61334331	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.001
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.009
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	5925	usd
CY2022	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	12994	usd
CY2023	jrss	After Tax Net Income Percentage AfterTaxNetIncomePercentage	0.10	pure
CY2023	us-gaap	Public Utilities Approved Debt Capital Structure Percentage PublicUtilitiesApprovedDebtCapitalStructurePercentage	0.50	pure
CY2022	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	1335401	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	75982	usd
CY2022	us-gaap	Accounts Receivable Purchase AccountsReceivablePurchase	615247	usd
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2022Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2022	jrss	Inventories Imparementreturn InventoriesImparementreturn		usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties		usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
CY2023	jrss	Proceeds From Financing Lease ProceedsFromFinancingLease		usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q4	jrss	Vat Deductible VATDeductible		usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables		usd
CY2023Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent		usd
CY2022Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent		usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2023Q4	jrss	Finance Lease Liabilitiesnoncurrent FinanceLeaseLiabilitiesnoncurrent		usd
CY2022Q4	jrss	Finance Lease Liabilitiesnoncurrent FinanceLeaseLiabilitiesnoncurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023	jrss	Finance Lease Cost FinanceLeaseCost		usd
CY2022	jrss	Finance Lease Cost FinanceLeaseCost		usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost		usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost		usd
CY2022	us-gaap	Sublease Income SubleaseIncome		usd
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement		usd
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement		usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent		pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent		usd
CY2023Q4	jrss	Social Security Payable SocialSecurityPayable		usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61334331	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77253156	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.001
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.009
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001597892
CY2023	dei	No Trading Symbol Flag NoTradingSymbolFlag	true

Files In Submission

Name	View Source	Status
0001213900-24-036467-index-headers.html	Edgar Link	pending
0001213900-24-036467-index.html	Edgar Link	pending
0001213900-24-036467.txt	Edgar Link	pending
0001213900-24-036467-xbrl.zip	Edgar Link	pending
ea0204092-10k_jrsis.htm	Edgar Link	pending
ea020409201ex21_jrsis.htm	Edgar Link	pending
ea020409201ex31-1_jrsis.htm	Edgar Link	pending
ea020409201ex32-1_jrsis.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
f_001.jpg	Edgar Link	pending
f_002.jpg	Edgar Link	pending
f_003.jpg	Edgar Link	pending
image_001.jpg	Edgar Link	pending
jrss-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
jrss-20231231_cal.xml	Edgar Link	unprocessable
jrss-20231231_def.xml	Edgar Link	unprocessable
jrss-20231231_lab.xml	Edgar Link	unprocessable
jrss-20231231_pre.xml	Edgar Link	unprocessable
ea0204092-10k_jrsis_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JRSS
JRSIS HEALTH CARE Corp Stock $jrss

2024 Q2 Form 10-K Financial Statement

#000121390024036467 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JRSS JRSIS HEALTH CARE Corp Stock $jrss

2024 Q2 Form 10-K Financial Statement

#000121390024036467 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JRSS
JRSIS HEALTH CARE Corp Stock $jrss